A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG)
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Screening and diagnostic criteria for gestational diabetes (GDM) are inconsistent across Europe, and the development of a uniform GDM screening strategy is necessary. Such a strategy would create opportunities for more women to receive timely treatment for GDM. Developing a consensus on screening for GDM in Europe is challenging, as populations are diverse and healthcare delivery systems also differ. The European Board & College of Obstetrics and Gynaecology (EBCOG) has responded to this challenge by appointing a steering committee, including members of the EBCOG and the Diabetic Pregnancy Study Group (DPSG) associated with the EASD, to develop a proposal for the use of uniform diagnostic criteria for GDM in Europe. A proposal has been developed and has now been approved by the Council of the EBCOG. The current proposal is to screen for overt diabetes at the first prenatal contact using cut-off values for diabetes outside pregnancy, with particular efforts made to screen high-risk groups. When screening for GDM is performed at 24 weeks' gestation or later, the proposal is now to use the 75 g OGTT with the new WHO diagnostic criteria for GDM. However, more research is necessary to evaluate the best GDM screening strategy for different populations in Europe. Therefore, no clear recommendation has been made on whether a universal one-step, two-step or a risk-factor-based screening approach should be used. The use of the same WHO diagnostic GDM criteria across Europe will be an important step towards uniformity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, due to concerns concerning the increased workload and associated costs, the adoption of the IADPSG screening strategy varies worldwide [57].”
From The Risk for Glucose Intolerance after Gestational Diabetes Mellitus since the Introduction of the IADPSG Criteria: A Systematic Review and Meta-Analysis (2019) · cites this paper as [57]
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Weight Gain During Pregnancy: Reexamining the Guidelines
Rasmussen, K. M., & Yaktine, A. L. (2009) · Cited by 4,473
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 1×
“Shortly after delivery, glucose homeostasis is generally restored to normal, but women with GDM are at high risk of developing type 2 diabetes [48].”
BackgroundInternational Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Basevi, V., Di Mario, S., Morciano, C., Nonino, F., & Magrini, N. (2011) · Diabetes Care · doi:10.2337/dc11-0174 · Cited by 3,055
Buchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 2×
“No intervention trials have been performed using the new WHO criteria, but two large intervention trials have shown that treatment of mild forms of GDM is associated with decreased rates of fetal overgrowth and pre-eclampsia [3, 4].”
BackgroundMethodMetzger, B. E., Buchanan, T. A., Coustan, D. R., de Leiva, A., Dunger, D. B., Hadden, D. R., Hod, M., Kitzmiller, J. L., Kjos, S. L., Oats, J. N., et al. (2007) · Diabetes Care · doi:10.2337/dc07-s225 · Cited by 1,908
(1964) · PubMed · Cited by 1,230
The Hyperglycemia and Adverse Pregnancy Outcome Study
Catalano, P. M., McIntyre, H. D., Cruickshank, J. K., McCance, D. R., Dyer, A. R., Metzger, B. E., Lowe, L. P., Trimble, E. R., Coustan, D. R., Hadden, D. R., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1790 · Cited by 954 · cited 1×
“This is confirmed by analyses of the HAPO study showing that both maternal GDM and obesity are independently associated with adverse pregnancy outcomes such as LGA, pre-eclampsia, Caesarean section and newborn percentage body fat >90th percentile and that the combination of obesity and GDM confers a greater risk of th…”
Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy
Agarwal, M., Boulvain, M., Coetzee, E. J., Colagiuri, S., Falavigna, M., Hod, M., Meltzer, S. J., Metzger, B. E., Omori, Y., Rasa, I., et al. (2013) · Cited by 759
Lawrence, J. M., Contreras, R., Chen, W., & Sacks, D. A. (2008) · Diabetes Care · doi:10.2337/dc07-2345 · Cited by 658
Practice Bulletin No. 137: Gestational Diabetes Mellitus
(2013) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000433006.09219.f1 · Cited by 581
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561 · cited 1×
“In 2013 both the WHO and the Endocrine Society revised their guidelines and now advise that the IADPSG criteria should be used for the diagnosis of GDM [19, 20].”
MethodCommittee Opinion No. 549: Obesity in Pregnancy
(2013) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000425667.10377.60 · Cited by 372
Buckley, B. S., Harreiter, J., Damm, P., Corcoy, R., Chico, A., Simmons, D., Vellinga, A., Dunne, F., & on behalf of the DALI Core Investigator Group (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03541.x · Cited by 360
Self-citationOteng-Ntim, E., Varma, R., Croker, H., Poston, L., & Doyle, P. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-47 · Cited by 352 · cited 1×
“A recent meta-analysis has shown that lifestyle intervention in obese pregnant women reduces maternal weight gain, but without differences in rates of Caesarean section, LGA or macrosomia [38].”
MethodZhu, W.-W., Yang, H.-X., Wei, Y.-M., Yan, J., Wang, Z.-L., Li, X.-L., Wu, H.-R., Li, N., Zhang, M.-H., Liu, X.-H., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1157 · Cited by 338 · cited 1×
“first prenatal visit as the criterion for GDM diagnosis in a Chinese population [11].”
BackgroundDuran, A., Sáenz, S., Torrejón, M. J., Bordiú, E., del Valle, L., Galindo, M., Perez, N., Herraiz, M. A., Izquierdo, N., Rubio, M. A., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0179 · Cited by 335 · cited 1×
“Moreover, a recent Spanish cohort study showed that, compared with the previous two-step screening strategy using the Carpenter and Coustan criteria, the one-step approach with the IADPSG criteria was associated with reduced rates of adverse pregnancy outcomes and was also cost effective [44].”
ResultThe association between pregnancy weight gain and birthweight: a within-family comparison
Ludwig, D. S., & Currie, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60751-9 · Cited by 321
Gestational diabetes mellitus: results from a survey of country prevalence and practices
Jiwani, A., Marseille, E., Lohse, N., Damm, P., Hod, M., & Kahn, J. G. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2011.587921 · Cited by 316 · cited 1×
“Recent surveys demonstrate the strong variability internationally in screening, diagnosis and treatment of women with GDM [22].”
BackgroundSelf-citationJenum, A. K., Mørkrid, K., Sletner, L., Vange, S., Torper, J. L., Nakstad, B., Voldner, N., Rognerud-Jensen, O. H., Berntsen, S., Mosdøl, A., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0866 · Cited by 290
(2013) · PubMed · Cited by 279
First-Trimester Fasting Hyperglycemia and Adverse Pregnancy Outcomes
Riskin-Mashiah, S., Younes, G., Damti, A., & Auslender, R. (2009) · Diabetes Care · doi:10.2337/dc09-0688 · Cited by 277
Webber, J., Charlton, M., & Johns, N. (2015) · British Journal of Diabetes · doi:10.15277/bjdvd.2015.029 · Cited by 245
Diagnosing gestational diabetes
Ryan, E. A. (2011) · Diabetologia · doi:10.1007/s00125-010-2005-4 · Cited by 205 · cited 1×
“The main discussion now is around the threshold at which hyperglycaemic treatment of GDM becomes cost effective [42, 43].”
BackgroundNankervis, A. J., McIntyre, D. H., Moses, R. G., Gp, R., Callaway, L. K., Porter, C., Jeffries, W. S., & Boorman, C. (2014) · Cited by 195
Werner, E. F., Pettker, C. M., Zuckerwise, L., Reel, M., Funai, E. F., Henderson, J., & Thung, S. F. (2012) · Diabetes Care · doi:10.2337/dc11-1643 · Cited by 182
Agarwal, M. M., Dhatt, G. S., & Shah, S. M. (2010) · Diabetes Care · doi:10.2337/dc10-0572 · Cited by 181
Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycaemia
Ricart, W., López, J., Mozas, J., Pericot, A., Sancho, M. A., González, N., Balsells, M., Luna, R., Cortázar, A., Navarro, P., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1877-1 · Cited by 164 · cited 1×
“Maternal obesity is also a major independent risk factor for gestational hypertension, congenital abnormalities and birth trauma [37].”
BackgroundSelf-citationGestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear
Cundy, T., Ackermann, E., & Ryan, E. A. (2014) · BMJ · doi:10.1136/bmj.g1567 · Cited by 158 · cited 2×
“Comments have been raised about the paucity of data on cost effectiveness of such a screening strategy, uncertainties about the clinical relevance of treating mild GDM based on the IADPSG criteria and the risk of progression from mild GDM to type 2 diabetes mellitus postpartum, and the lack of clinical controlled tria…”
BackgroundHemoglobin A1c Versus Oral Glucose Tolerance Test in Postpartum Diabetes Screening
Picón, M. J., Murri, M., Muñoz, A., Fernández-García, J. C., Gomez-Huelgas, R., & Tinahones, F. J. (2012) · Diabetes Care · doi:10.2337/dc11-2111 · Cited by 122
Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis
Mission, J. F., Ohno, M. S., Cheng, Y. W., & Caughey, A. B. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.06.048 · Cited by 111 · cited 1×
“So far, two studies have addressed the cost effectiveness of GDM screening according to the IADPSG criteria using decision-analysis models for a US population [14, 15].”
MethodFasting Plasma Glucose at 24–28 Weeks to Screen for Gestational Diabetes Mellitus
Zhu, W.-W., Fan, L., Yang, H.-X., Kong, L.-Y., Su, S.-P., Wang, Z.-L., Hu, Y.-L., Zhang, M.-H., Sun, L.-Z., Mi, Y., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2465 · Cited by 88
Modeling the Independent Effects of Gestational Diabetes Mellitus on Maternity Care and Costs
Gillespie, P., Cullinan, J., O’Neill, C., Dunne, F., & Collaborators, F. T. A. D. (2013) · Diabetes Care · doi:10.2337/dc12-0461 · Cited by 69 · cited 1×
“Recent modelling based on data from the ATLANTIC Diabetes in Pregnancy (DIP) study shows that GDM plays an independent role in explaining variations in rates of emergency Caesarean section, neonatal unit admission and costs of care, and thus places a substantial economic burden on maternity care services [16].”
MethodSelf-citationThe Importance of a Postpartum 75 g Oral Glucose Tolerance Test in Women With Gestational Diabetes
Reinblatt, S. L., Morin, L. M., & Meltzer, S. J. (2006) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32230-7 · Cited by 45 · cited 1×
“It is acknowledged that this recommendation is largely based on expert opinion or common clinical practice [8, 49].”
BackgroundEvolution of diagnostic criteria for gestational diabetes mellitus
Houshmand‐Oeregaard, A. S., Jensen, D. M., Mathiesen, E. R., & Damm, P. (2013) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12152 · Cited by 42 · cited 2×
“Other countries use risk-factor-based or universal screening and the criteria of the EASD or the National Diabetes Data Group [31, 32]; see Text box: Commonly used screening strategies for GDM in Europe.”
MethodSelf-citationThe Association Between Pregnancy Weight Gain and Birthweight: A Within-family Comparison
Ludwig, D. S., & Currie, J. (2011) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000406669.86787.0a · Cited by 41 · cited 1×
“Gestational weight gain is also a known independent risk factor for accelerated fetal growth [39].”
BackgroundDiagnosis of Gestational Diabetes Mellitus in China
Zhu, W.-W., & Yang, H.-X. (2013) · Diabetes Care · doi:10.2337/dc12-2624 · Cited by 40
Screening for hyperglycaemia in pregnancy: Consensus and controversy
Waugh, N. R., Pearson, D. W. M., & Royle, P. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.06.004 · Cited by 35 · cited 1×
“The main discussion now is around the threshold at which hyperglycaemic treatment of GDM becomes cost effective [42, 43].”
BackgroundBühling, K. J., Elze, L., Henrich, W., Starr, E., Stein, U., Siebert, G., & Dudenhausen, J. W. (2003) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2003.06.013 · Cited by 33 · cited 1×
“The measurement of glycosuria alone is not advised as this has a very low sensitivity and is also often falsely positive in pregnancy [35].”
BackgroundCorcoy, R., Lumbreras, B., Bartha, J. L., & Ricart, W. (2010) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2010.03.007 · Cited by 20 · cited 2×
“Other countries use risk-factor-based or universal screening and the criteria of the EASD or the National Diabetes Data Group [31, 32]; see Text box: Commonly used screening strategies for GDM in Europe.”
MethodSelf-citationBenhalima, K., Van Crombrugge, P., Devlieger, R., Verhaeghe, J., Verhaegen, A., De Catte, L., & Mathieu, C. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-66 · Cited by 18 · cited 2×
“Some countries and regions in Europe use selective screening with the previous WHO diagnostic criteria (the UK and the Netherlands, for example), while others use the ACOG screening strategy (the Flemish part of Belgium, for example) [24, 29, 30].”
BackgroundMethodSelf-citationOteng‐Ntim, E., Tezcan, B., Seed, P. T., Poston, L., & Doyle, P. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00899-5 · Cited by 13
Hyperglycaemia in pregnancy in Mediterranean women
MGSD:GDM Study Group, Savona‐Ventura, C., Vassallo, J., Marre, M., & Karamanos, B. G. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0427-9 · Cited by 12 · cited 1×
“7%, respectively [47].”
Self-citationCorcoy, R., Lumbreras, B., Bartha, J. L., & Ricart, W. (2010) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.03.020 · Cited by 11
Self-citationDiabetes mellitus en zwangerschap
Hofsteenge, G. H. (2013) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-0508-7_18 · Cited by 6
[Screening strategy and diagnostic criteria for gestational diabetes. Proposals of the GGOLFB].
Vanderijst, J.-F., Debiève, F., Doucet, F., Emonts, P., Haumont, S., Hubinont, C., Kirkpatrick, C., Philips, J. C., Pintiaux, A., Rousseau, P., et al. (2012) · PubMed · Cited by 6
Research works printed but not linked: 1
- Vanderijst J-F, Debieve F, Doucet F et al (2012) Stratégie de dépistage et critères diagnostiques du diabète gestationnel. Propositions du GGOLFB. Rev Med Liege 67(4):179–185, [article in French]
Cited by
McIntyre, H. D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E. R., & Damm, P. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0098-8 · Cited by 1,850
Self-citationA Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
Epidemiology and management of gestational diabetes
Sweeting, A., Hannah, W., Backman, H., Catalano, P., Feghali, M., Herman, W. H., Hivert, M.-F., Immanuel, J., Meek, C., Oppermann, M. L., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00825-0 · Cited by 431
Self-citationon behalf of the DALI Core Investigator group, Egan, A. M., Vellinga, A., Harreiter, J., Simmons, D., Desoye, G., Corcoy, R., Adelantado, J. M., Devlieger, R., Van Assche, A., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4353-9 · Cited by 152
“The aim of this study was to use information collected during the Vitamin D and Lifestyle Intervention for Gestational Diabetes Mellitus Prevention (DALI) trial to determine risk factors for GDM development and examine the prevalence of GDM in pregnancy among high-risk women 13 Department of Endocrinology, Odense Univ…”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Benhalima, K., Mathieu, C., Damm, P., Van Assche, A., Devlieger, R., Desoye, G., Corcoy, R., Mahmood, T., Nizard, J., Savona-Ventura, C., & Dunne, F.
- Affiliations
- Universitair Ziekenhuis Leuven (BE)
- University of Copenhagen (DK)
- Hospital de Sant Pau (ES)
- University of Edinburgh (GB)
- Assistance Publique – Hôpitaux de Paris (FR)
- Ollscoil na Gaillimhe – University of Galway (IE)
- Corresponding author
- Benhalima, Katrien
- ORCID
- Venue
- Diabetologia
- Published
- 2015-05-08
- Volume
- 58
- Issue
- 7
- Pages
- 1422-1429
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2126809168
- Cited by
- 72
- References
- 53
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 9 · 2019: 7 · 2018: 13 · 2017: 6 · 2016: 7 · 2015: 3
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-05-18)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (acceptedVersion, cc-by-nc-nd)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (submittedVersion, cc-by-nc-nd)
- Lirias (submittedVersion)
- University of Galway Research Repository (submittedVersion, cc-by-nc)
- Research Repository UCD (University College Dublin) (cc-by-nc)
- Funders
- Health Research Board
- Fonds Wetenschappelijk Onderzoek
- Vlaamse regering
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- gestational diabetes mellitus, diagnostic criteria, prenatal screening, 75 g oral glucose tolerance test, WHO diagnostic criteria, screening method, high-risk groups, European consensus, risk factor-based screening
- MeSH terms
- Adult, Europe, Female, Glucose Tolerance Test, Gynecology, Humans, Mass Screening, Obstetrics, Pregnancy, Reference Standards, Risk Factors, World Health Organization, Diabetes, Gestational, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.